U.S. markets open in 9 hours 30 minutes
  • S&P Futures

    4,627.25
    -27.50 (-0.59%)
     
  • Dow Futures

    35,670.00
    -126.00 (-0.35%)
     
  • Nasdaq Futures

    15,426.50
    -169.25 (-1.09%)
     
  • Russell 2000 Futures

    2,145.20
    -12.50 (-0.58%)
     
  • Crude Oil

    84.83
    +1.01 (+1.20%)
     
  • Gold

    1,816.30
    -0.20 (-0.01%)
     
  • Silver

    22.90
    -0.02 (-0.10%)
     
  • EUR/USD

    1.1405
    -0.0005 (-0.05%)
     
  • 10-Yr Bond

    1.7720
    +0.0610 (+3.57%)
     
  • Vix

    19.19
    -1.12 (-5.51%)
     
  • GBP/USD

    1.3640
    -0.0007 (-0.05%)
     
  • USD/JPY

    114.8550
    +0.2750 (+0.24%)
     
  • BTC-USD

    42,086.98
    -707.11 (-1.65%)
     
  • CMC Crypto 200

    1,009.32
    -16.41 (-1.60%)
     
  • FTSE 100

    7,611.23
    +68.28 (+0.91%)
     
  • Nikkei 225

    28,253.23
    -80.29 (-0.28%)
     

TELA Bio to Participate in Canaccord Genuity’s 41st Annual Growth Conference

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

MALVERN, Pa., Aug. 03, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today announced that the Company will participate in Canaccord Genuity’s 41st Annual Growth Conference.

TELA Bio's management is scheduled to present at Canaccord Genuity’s 41st Annual Growth Conference on Thursday, August 12, 2021 at 2:00 PM EDT. Interested parties can access the live and archived webcast at ir.telabio.com.

About TELA Bio, Inc.
TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The Company is committed to providing patients with advanced, economically effective biologic material repair solutions to minimize long-term exposure to permanent synthetic materials and improve clinical outcomes. TELA Bio's OviTex® and OviTex PRS Reinforced Tissue Matrix products are purposefully designed to address the shortcomings of existing reinforcement materials in hernia repair, abdominal wall reconstruction, and plastic and reconstructive surgery. For more information, visit www.telabio.com.

Investor Contact
Greg Chodaczek
347-620-7010
ir@telabio.com